retatrutide triple agonist gip glp-1 glucagon phase 2 obesity trial ✨ Retatrutide: The Next Evolution in Weight Loss Medications ✨ You may be hearing the informal term “GLP-3” — but what does that actually mean? is a new triple-agonist medication that Retatrutide (LY3437943), a Novel GIP/GLP-1/Glucagon
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Oct 8 - Oct 13


























